ACM
SUPN icon

Allred Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Allred Capital Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-75
Closed -$1.96K – 691
2021
Q1 		$1.96K Buy
+75
New +$2.1K ﹤0.01% 799

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Allred Capital Management's SUPN Position: Q2 2021 in Review

Allred Capital Management sold out of Supernus Pharmaceuticals (SUPN) in Q2 2021, closing a stake of 75 shares — an estimated $1.96K sold.

Allred Capital Management first reported a position in SUPN in Q1 2021 and held it in 1 quarter. The position peaked at $1.96K in Q1 2021. 226 funds tracked by Wall St. Rank hold SUPN as of Q2 2021.

  • Allred Capital Management reported no remaining Supernus Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Allred Capital Management sold 75 Supernus Pharmaceuticals shares in Q2 2021, an estimated $1.96K.
  • Allred Capital Management first reported a position in Supernus Pharmaceuticals in Q1 2021 and held it in 1 quarter.
  • Allred Capital Management's Supernus Pharmaceuticals position peaked at $1.96K in Q1 2021.
  • 226 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2021.

Based on Allred Capital Management's 13F filing for Q2 2021, filed 5 Aug 2021.